Transcranial Electrical Stimulatio… for Parkinson's (NCT07182058)
Improve walking through transcranial stimulation
- Trial ID
- NCT07182058
- Official Title
- Virtual Remote Assessment of Transcranial Electrical Stimulation for Parkinson's Disease Motor Symptoms
- Goal
- Improve walking through transcranial stimulation
- Phase
- PHASE1, PHASE2
- Status
- RECRUITING
- Sponsor
- U: The Mind Company
- Study Type
- INTERVENTIONAL
- Enrollment
- 30 participants
- Conditions
- PARKINSON DISEASE (Disorder)
- Interventions
- Transcranial Electrical Stimulation Device
Summary For Families
It aims to ease motor symptoms like tremor, slowness, and stiffness by testing whether remotely delivered transcranial electrical stimulation can safely improve movement in people with Parkinson's. The device sends gentle, low-level electrical currents through the scalp to tweak the excitability of motor brain circuits, sessions are done at home with telehealth supervision, and it is studied as an add-on rather than a replacement for levodopa or other Parkinson's medications so participants need a stable regimen. Looking for adults 18 to 80 with Parkinson's at Hoehn and Yahr stages 1 to 4 who have stable meds and reliable internet; people with metal head or neck implants, a history of seizures, recent stroke, pregnancy, severe cognitive impairment, serious skin problems at electrode sites, or current participation in other trials are excluded.
Locations
- U LLC Headquarters, Cleveland, Ohio, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Transcranial Electrical Stimulation Device. It aims to ease motor symptoms like tremor, slowness, and stiffness by testing whether remotely delivered transcranial electrical stimulation can safely improve movement in people with Parkinson's. The device sends gentle, low-level electrical currents through the scalp to tweak the excitability of motor brain circuits, sessions are done at home with telehealth supervision, and it is studied as an add-on rather than a replacement for levodopa or other Parkinson's medications so participants need a stable regimen. Looking for adults 18 to 80 with Parkinson's at Hoehn and Yahr stages 1 to 4 who have stable meds and reliable internet; people with metal head or neck implants, a history of seizures, recent stroke, pregnancy, severe cognitive impairment, serious skin problems at electrode sites, or current participation in other trials are excluded.
- Who can participate?
- Participants must be between 18 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This Phase 1/Phase 2 trial is estimated to last approximately 2 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- Everyone in this trial receives the experimental treatment. There is no placebo group.
- How many visits does this trial involve?
- There are no in-person visits; the study is conducted virtually and lasts 6 weeks.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.